Vicore Webcast: Buloxibutid and the Evolving IPF Landscape

Report on the ATTRACT study

Untangling the dualistic components of the RAS in PF the Yin and Yang

C21 shows promise against COVID-19 where other drugs have failed

Idiopathic Pulmonary Fibrosis (IPF) – weathering the pandemic

Interview with Ella Radvogin, Clinical Psychologist at Alex Therapeutics